-
Novo Nordisk pours $112m investment into Chinese manufacturing hub
15 Jul 2025 13:14 GMT
… wind energy for operation. Novo Nordisk will fund a series … now overweight or obese.
Novo Nordisk is a large pharmaceutical … products, semaglutide weight-loss drug Wegovy, has recently been … using semaglutide and similar drugs to tackle obesity.
Related …
-
Wegovy, Zepbound prices fall, but access to obesity drugs still isn’t guaranteed
15 Jul 2025 16:21 GMT
… but steady access to the drugs remains challenging.
The medications … 's best sellers.
Novo Nordisk said Wegovy has about 200 … , doctor said.
Cheaper compounded drugs are still being sold
Compounding … of the drugs. But the U.S. Food and Drug Administration …
-
Obesity drugs may raise testosterone in men
15 Jul 2025 19:53 GMT
… therapy.
SAN FRANCISCO — Incretin-based drugs, such as semaglutide and tirzepatide … Lilly), semaglutide (Ozempic/Wegovy, Novo Nordisk) and tirzepatide (Mounjaro/Zepbound … who initiated an incretin-based drug.
Men who used dulaglutide, semaglutide …
-
Kailera touts late-stage win for weight-loss drug in China
15 Jul 2025 14:24 GMT
… ' experimental weight-loss drug has helped overweight patients lose … of participants who received the drug, known as KAI-9531 … stage funding and four obesity drug candidates licensed from Hengrui, … s Zepbound and Novo Nordisk's Wegovy.
The drugs work by …
-
First New PTSD Drug in Two Decades On the Horizon?
15 Jul 2025 08:03 GMT
The Psychopharmacologic Drugs Advisory Committee of … to consider a supplemental new drug application for brexpiprazole (Rexulti … As with any new drug application, several questions and … , Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra- …
-
Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over “Deceptive” Marketing of Wegovy – Hagens Berman
14 Jul 2025 15:26 GMT
… follow an announcement by Novo Nordisk that it terminated its … of the weight loss drug Wegovy® which precipitated a … amp; Hers’ collaboration with Novo Nordisk would be terminated. Investors learned … mass sales of compounded drugs under false guise of …
-
Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over “Deceptive” Marketing of Wegovy– Hagens Berman
11 Jul 2025 13:59 GMT
… follow an announcement by Novo Nordisk that it terminated its … of the weight loss drug Wegovy® which precipitated a … amp; Hers’ collaboration with Novo Nordisk would be terminated. Investors learned … mass sales of compounded drugs under false guise of …
-
3 Reasons I Bought Novo Nordisk Stock Instead of Eli Lilly
10 Jul 2025 02:16 GMT
… Investors appear to be underestimating Novo Nordisk
Eli Lilly has been stealing … sheer weight loss. A drug needs to be well tolerated … can help Novo Nordisk, as that can make its drugs default options … investing more into GLP-1 drug development. This is a …
-
Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over “Deceptive” Marketing of Wegovy – Hagens Berman
09 Jul 2025 21:19 GMT
… follow an announcement by Novo Nordisk that it terminated its … of the weight loss drug Wegovy® which precipitated a … amp; Hers’ collaboration with Novo Nordisk would be terminated. Investors learned … mass sales of compounded drugs under false guise of …
-
Hims & Hers Announces Plans To Expand Into Canada As Novo Nordisk’s Weight Loss Drug Patent Expires
09 Jul 2025 18:48 GMT
… in Novo Nordisk’s branded diabetes and weight loss drugs Ozempic … X.
Late last month, Novo Nordisk announced that it is … versions of brand-name drugs. Compounded drugs, on the other … FDA-approved drug is unavailable or unsuitable. Compounded drugs are not …
About
© 1995-2025